BIOMAT Database Logo BIOMAT Database Logo

Model system for removing neuroblastoma cells from bone marrow using monoclonal antibodies and magnetic immunobeads. 1986

C P Reynolds, and R C Seeger, and D D Vo, and A T Black, and J Wells, and J Ugelstad

Variables effecting removal of neuroblastoma cells from bone marrow using monoclonal antibodies and magnetic immunobeads were studied. Human neuroblastoma cell lines were labeled with the supravital DNA stain Hoechst 33342, seeded into normal bone marrow, incubated with monoclonal antibodies recognizing neuroblastoma cell surface antigens (HSAN 1.2, antibody 459, antibody 390, BA-1, and Leu-7), and then mixed with magnetic microspheres coated with goat anti-mouse immunoglobulin. Tumor cells that attached to the magnetic immunobeads were then removed from the marrow with magnets. The efficacy of tumor cell removal depended on the amount of monoclonal antibody bound to tumor cells and the immunobead/tumor cell ratio. In addition, two cycles of purging with both monoclonal antibodies and immunobeads was superior to one cycle. Using a cocktail of the five antibodies, 3 to 4 logs of tumor cells could be depleted from marrow with good recovery of viable hematopoietic cells.

UI MeSH Term Description Entries
D008280 Magnetics The study of MAGNETIC PHENOMENA. Magnetic
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009447 Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) Neuroblastomas
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D006412 Hematopoietic Stem Cells Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood. Colony-Forming Units, Hematopoietic,Progenitor Cells, Hematopoietic,Stem Cells, Hematopoietic,Hematopoietic Progenitor Cells,Cell, Hematopoietic Progenitor,Cell, Hematopoietic Stem,Cells, Hematopoietic Progenitor,Cells, Hematopoietic Stem,Colony Forming Units, Hematopoietic,Colony-Forming Unit, Hematopoietic,Hematopoietic Colony-Forming Unit,Hematopoietic Colony-Forming Units,Hematopoietic Progenitor Cell,Hematopoietic Stem Cell,Progenitor Cell, Hematopoietic,Stem Cell, Hematopoietic,Unit, Hematopoietic Colony-Forming,Units, Hematopoietic Colony-Forming
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000912 Antibodies, Neoplasm Immunoglobulins induced by antigens specific for tumors other than the normally occurring HISTOCOMPATIBILITY ANTIGENS. Neoplasm Antibodies,Tumor Antibodies,Antibodies, Tumor

Related Publications

C P Reynolds, and R C Seeger, and D D Vo, and A T Black, and J Wells, and J Ugelstad
Elimination of clonogenic leukemic cells from bone marrow using monoclonal antibodies and magnetic immunobeads.
January 1990, Progress in clinical and biological research,
C P Reynolds, and R C Seeger, and D D Vo, and A T Black, and J Wells, and J Ugelstad
Elimination of myeloma cells from bone marrow by using monoclonal antibodies and magnetic immunobeads.
October 1988, Blood,
C P Reynolds, and R C Seeger, and D D Vo, and A T Black, and J Wells, and J Ugelstad
Purging of myeloma cells from bone marrow using monoclonal antibodies and magnetic immunobeads in combination with 4-hydroperoxycyclophosphamide.
January 1990, Progress in clinical and biological research,
C P Reynolds, and R C Seeger, and D D Vo, and A T Black, and J Wells, and J Ugelstad
Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres.
January 1984, Lancet (London, England),
C P Reynolds, and R C Seeger, and D D Vo, and A T Black, and J Wells, and J Ugelstad
Removal of malignant cells from bone marrow using magnetic microspheres and monoclonal antibodies.
January 1985, Progress in experimental tumor research,
C P Reynolds, and R C Seeger, and D D Vo, and A T Black, and J Wells, and J Ugelstad
Magnetic microspheres and monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow: experiences, improvements and observations.
November 1986, British journal of cancer,
C P Reynolds, and R C Seeger, and D D Vo, and A T Black, and J Wells, and J Ugelstad
Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies.
March 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
C P Reynolds, and R C Seeger, and D D Vo, and A T Black, and J Wells, and J Ugelstad
Monoclonal antibodies for detecting bone marrow invasion by neuroblastoma.
April 1989, Journal of clinical pathology,
C P Reynolds, and R C Seeger, and D D Vo, and A T Black, and J Wells, and J Ugelstad
Detection of neuroblastoma cells in human bone marrow using a combination of monoclonal antibodies.
January 1982, Hybridoma,
C P Reynolds, and R C Seeger, and D D Vo, and A T Black, and J Wells, and J Ugelstad
Monoclonal antibodies and magnetic microspheres used for the depletion of malignant cells from bone marrow.
January 1985, Progress in clinical and biological research,
Copied contents to your clipboard!